Sign Up to like & get
recommendations!
2
Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2160315
Abstract: ABSTRACT Introduction IgA nephropathy (IgAN) is the commonest primary glomerulonephritis worldwide and may progress to end-stage kidney disease (ESKD) within a 10–20 year period. Its slowly progressive course has made clinical trials challenging to perform,…
read more here.
Keywords:
iga nephropathy;
clinical trials;
overview drug;
nephropathy overview ... See more keywords